UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

2017 Clinical trials update: Innovations in hemophilia therapy

American journal of hematology, 2016-12, Vol.91 (12), p.1252-1260

2016

Volltextzugriff (PDF)

Kaposiform Hemangioendothelioma: Atypical Features and Risks of Kasabach-Merritt Phenomenon in 107 Referrals

The Journal of pediatrics, 2013-01, Vol.162 (1), p.142-147

2013

Volltextzugriff (PDF)

2021 clinical trials update: Innovations in hemophilia therapy

American journal of hematology, 2021-01, Vol.96 (1), p.128-144

2021

Volltextzugriff (PDF)

Kaposiform Lymphangiomatosis: A Distinct Aggressive Lymphatic Anomaly

The Journal of pediatrics, 2014-02, Vol.164 (2), p.383-388

2014

Volltextzugriff (PDF)

Hemophilia A/B

Hematology/oncology clinics of North America, 2022-08, Vol.36 (4), p.797-812

Croteau, Stacy E.

2022

Volltextzugriff (PDF)

Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A

The New England journal of medicine, 2021-11, Vol.385 (21), p.1961-1973

2021

Volltextzugriff (PDF)

Benefits and risks of non‐factor therapies: Redefining haemophilia treatment goals in the era of new technologies

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-04, Vol.30 (S3), p.39-44

2024

Volltextzugriff (PDF)

Evolving Complexity in Hemophilia Management

The Pediatric clinics of North America, 2018-06, Vol.65 (3), p.407-425

Croteau, Stacy E.

2018

Volltextzugriff (PDF)

Bioengineering hemophilia A–specific microvascular grafts for delivery of full-length factor VIII into the bloodstream

Blood advances, 2019-12, Vol.3 (24), p.4166-4176

2019

Volltextzugriff (PDF)

Low von Willebrand factor in pediatric patients: Retrospective analysis of 293 cases informs diagnostic and therapeutic decision making

Pediatric blood & cancer, 2020-09, Vol.67 (9), p.e28497-n/a

2020

Volltextzugriff (PDF)

Pharmacokinetic‐tailored approach to hemophilia prophylaxis: Medical decision making and outcomes

Research and practice in thrombosis and haemostasis, 2020-02, Vol.4 (2), p.326-333

2020

Volltextzugriff (PDF)

Shifting landscape of hemophilia therapy: Implications for current clinical laboratory coagulation assays

American journal of hematology, 2018-08, Vol.93 (8), p.1082-1090

2018

Volltextzugriff (PDF)

Epidemiology and Risk Assessment of Pediatric Venous Thromboembolism

Frontiers in pediatrics, 2017-04, Vol.5, p.68-68

2017

Volltextzugriff (PDF)

Beliefs, opinions and impact of emicizumab in haemophilia A patients: A National US Survey Study

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-03, Vol.27 (2), p.e270-e273

2021

Volltextzugriff (PDF)

Development of a Risk Model for Pediatric Hospital-Acquired Thrombosis: A Report from the Children's Hospital-Acquired Thrombosis Consortium

The Journal of pediatrics, 2021-01, Vol.228, p.252-259.e1

2021

Volltextzugriff (PDF)

Discussing investigational AAV gene therapy with hemophilia patients: A guide

Blood reviews, 2021-05, Vol.47, p.100759-100759, Article 100759

2021

Volltextzugriff (PDF)

Spontaneous bleeding and poor bleeding response with extended half‐life factor IX products: A survey of select US haemophilia treatment centres

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-05, Vol.26 (3), p.e128-e129

2020

Volltextzugriff (PDF)

Decreased platelet surface phosphatidylserine predicts increased bleeding in patients with severe factor VIII deficiency

Journal of thrombosis and haemostasis, 2021-04, Vol.19 (4), p.976-982

2021

Volltextzugriff (PDF)

The eTHINK Study: Cognitive and Behavioral Outcomes in Children with Hemophilia

The Journal of pediatrics, 2024-09, Vol.272, p.114089, Article 114089

2024

Volltextzugriff (PDF)

Health care resource utilization and costs among adult patients with hemophilia A on factor VIII prophylaxis: an administrative claims analysis

Journal of managed care & specialty pharmacy, 2021-03, Vol.27 (3), p.316-326

2021

Volltextzugriff (PDF)

The clinical spectrum of kaposiform hemangioendothelioma and tufted angioma

Seminars in cutaneous medicine and surgery, 2016-09, Vol.35 (3), p.147-152

2016

Volltextzugriff (PDF)

Antithrombin-lowering in hemophilia: a closer look at fitusiran

Research and practice in thrombosis and haemostasis, 2023-05, Vol.7 (4), p.100179, Article 100179

2023

Volltextzugriff (PDF)

Evaluation of venous thromboembolism risk factors reveals subtype heterogenicity in children with central venous catheters: a multicenter study from the Children’s Hospital Acquired Thrombosis consortium

Journal of thrombosis and haemostasis, 2023-09, Vol.21 (9), p.2441-2450

2023

Volltextzugriff (PDF)

Phage display broadly identifies inhibitor‐reactive regions in von Willebrand factor

Journal of thrombosis and haemostasis, 2021-11, Vol.19 (11), p.2702-2709

2021

Volltextzugriff (PDF)

Corrigendum to ‘Evaluation of Venous Thromboembolism Risk Factors Reveals Subtype Heterogenicity in Children with Central Venous Catheters: A Multi-Center Study from the CHAT Consortium’ [Journal of Thrombosis and Haemostasis 21/9 (2023) 2441 - 2450]

Journal of thrombosis and haemostasis, 2023-12, Vol.21 (12), p.3658-3658

2023

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(82)
Berichte
(1)

Sprache

Englisch
(83)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

2017 Clinical trials update: Innovations in hemophilia therapy

Kaposiform Hemangioendothelioma: Atypical Features and Risks of Kasabach-Merritt Phenomenon in 107 Referrals

2021 clinical trials update: Innovations in hemophilia therapy

Kaposiform Lymphangiomatosis: A Distinct Aggressive Lymphatic Anomaly

Hemophilia A/B

Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A

Benefits and risks of non‐factor therapies: Redefining haemophilia treatment goals in the era of new technologies

Evolving Complexity in Hemophilia Management

Bioengineering hemophilia A–specific microvascular grafts for delivery of full-length factor VIII into the bloodstream

Low von Willebrand factor in pediatric patients: Retrospective analysis of 293 cases informs diagnostic and therapeutic decision making

Pharmacokinetic‐tailored approach to hemophilia prophylaxis: Medical decision making and outcomes

Shifting landscape of hemophilia therapy: Implications for current clinical laboratory coagulation assays

Epidemiology and Risk Assessment of Pediatric Venous Thromboembolism

Beliefs, opinions and impact of emicizumab in haemophilia A patients: A National US Survey Study

Development of a Risk Model for Pediatric Hospital-Acquired Thrombosis: A Report from the Children's Hospital-Acquired Thrombosis Consortium

Discussing investigational AAV gene therapy with hemophilia patients: A guide

Spontaneous bleeding and poor bleeding response with extended half‐life factor IX products: A survey of select US haemophilia treatment centres

Decreased platelet surface phosphatidylserine predicts increased bleeding in patients with severe factor VIII deficiency

The eTHINK Study: Cognitive and Behavioral Outcomes in Children with Hemophilia

Health care resource utilization and costs among adult patients with hemophilia A on factor VIII prophylaxis: an administrative claims analysis

The clinical spectrum of kaposiform hemangioendothelioma and tufted angioma

Antithrombin-lowering in hemophilia: a closer look at fitusiran

Evaluation of venous thromboembolism risk factors reveals subtype heterogenicity in children with central venous catheters: a multicenter study from the Children’s Hospital Acquired Thrombosis consortium

Phage display broadly identifies inhibitor‐reactive regions in von Willebrand factor

Corrigendum to ‘Evaluation of Venous Thromboembolism Risk Factors Reveals Subtype Heterogenicity in Children with Central Venous Catheters: A Multi-Center Study from the CHAT Consortium’ [Journal of Thrombosis and Haemostasis 21/9 (2023) 2441 - 2450]

Suchergebnisse filtern